On August 5, McKesson rose 3.38% in regular trading, trading at approximately $850.70/share, with turnover of $52.97 million. The stock rebounded sharply after falling over 3% in the prior session due to pre-earnings caution.

The company is scheduled to report FY2027 Q1 earnings after market close, with consensus estimates for adjusted EPS at $9.44. Multiple positive developments supported the recovery: Citigroup recently raised its price target to $1,000 from $945 while maintaining a Buy rating, and McKesson announced a 15% quarterly dividend increase to $0.94 per share, marking its 10th consecutive year of dividend growth. The prior quarter saw adjusted EPS of $11.69 beating estimates of $11.56, though revenue of $96.3 billion missed the $101.35 billion consensus, which had previously weighed on sentiment.

Within the Health Care Distributors sector, peers also traded higher, with Cencora Inc. up 3.83%, Cardinal Health up 1.64%, and Accendra Health Inc up 1.67%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)